Ophthalmology Times - Ophthalmology news, articles, and events
WEBEfficacy of novel eye drop to reverse cataracts after phase 1/2 study. By Lynda Charters. August 25th 2024. The drop improves vision by breaking up degraded protein complexes that cause lens clouding. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
EDTA chelation provides solution for band keratopathy
WEBOct 15, 2005 · Baltimore—Ethylene diamine tetra-acetic acid (EDTA) chelation offers a low-tech, low-cost, effective treatment for calcific band keratopathy associated with chronic uveitis and other disorders, said James P. Dunn, MD, at the Current Concepts in Ophthalmology meeting, sponsored by Johns Hopkins University School of Medicine and Ophthalmology Times.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in …
Extended depth-of-field lenses: Understanding a new player in …
WEBJun 20, 2022 · Recently, seeking to eliminate the problems derived from the multifocal decomposition of light, extended depth-of-field (EDOF) lenses have been developed. These seek to occupy the intermediate space between the monofocal lens, with which dysphotopsia is practically absent but provides no independence from glasses, and the multifocal lens, with ...
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Rethinking dry eye disease with acute steroid treatment
WEBDec 13, 2021 · Ophthalmologists now can prescribe a steroid for treatment of dry eye disease (DED) with the confidence that they are doing so on-label. The FDA has approved a topical steroid for the short-term (up to 2 weeks) acute treatment of the signs and symptoms of DED. Loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis; Kala Pharmaceuticals) has ...
Fluorometholone acetate: More benefit than meets the eye
WEBDec 11, 2019 · Fluorometholone is the active steroid in formulations used to treat ocular inflammation- however, it is what doesn’t meet the eye that makes the difference, i.e., the vehicle. If the vehicle prevents the drug from optimally penetrating through the ocular surface into the underlying tissue, the drug will not be as effective as if the ...
Skip to content